Correlation Between Apellis Pharmaceuticals and Immunocore Holdings
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Immunocore Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Immunocore Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Immunocore Holdings, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Immunocore Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Immunocore Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Immunocore Holdings.
Diversification Opportunities for Apellis Pharmaceuticals and Immunocore Holdings
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Apellis and Immunocore is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Immunocore Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunocore Holdings and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Immunocore Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunocore Holdings has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Immunocore Holdings go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Immunocore Holdings
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 1.58 times more return on investment than Immunocore Holdings. However, Apellis Pharmaceuticals is 1.58 times more volatile than Immunocore Holdings. It trades about 0.19 of its potential returns per unit of risk. Immunocore Holdings is currently generating about -0.02 per unit of risk. If you would invest 2,734 in Apellis Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 457.00 from holding Apellis Pharmaceuticals or generate 16.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Immunocore Holdings
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Immunocore Holdings |
Apellis Pharmaceuticals and Immunocore Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Immunocore Holdings
The main advantage of trading using opposite Apellis Pharmaceuticals and Immunocore Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Immunocore Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunocore Holdings will offset losses from the drop in Immunocore Holdings' long position.| Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. HCW Biologics | Apellis Pharmaceuticals vs. Scpharmaceuticals | Apellis Pharmaceuticals vs. Milestone Pharmaceuticals |
| Immunocore Holdings vs. Arcellx | Immunocore Holdings vs. Ventyx Biosciences | Immunocore Holdings vs. Vaxcyte | Immunocore Holdings vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world |